Second Brazilian Consensus Conference on Helicobacter pylori Infection;II Consenso Brasileiro sobre Helicobacter pylori

Arquivos de Gastroenterologia

Volumn 42, Issue 2, 2005, Pages 128-132

  Coelho, Luiz Gonzaga Vaz ^a,c   Zaterka, Schlioma ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Rua Dos Otoni 712/304   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

BRAZIL; CONFERENCE PAPER; CONSENSUS; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; PRACTICE GUIDELINE;

EID: 23644431875     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032005000200012     Document Type: Conference Paper

References (26)

1. Coelho LG, León-Barúa R, Quigley EM. Latin-American Consensus Conference on Helicobacter pylori Infection. Am J Gastroenterol 2000;95:2688-91.
2. Coelho LGV, Barros CAS, Lima DCA, Barbosa AJA, Magalães AFN, Oliveira CA, Queiroz DMM, Cordeiro F, Rezende JM, Castro LP, Tolentino MM, Haddad MT, Zaterka S. Consenso Nacional sobre H. pylori e afecções associadas. GED Gastroenterol Endosc Dig 1996;15:53-8.
3. Coelho LGV, Mattos AA, Francisconi CFM, Castro LP, André SB. Eficácia do regime terapêutico empregando a associação de pantoprazol, claritromicina e amoxicilina, durante uma semana, na erradicação do Helicobacter pylori em pacientes com úlcera péptica. Arq Gastroenterol 2004;41:71-6.
4. Coelho LGV, Moretzsohn LD, Vieira WLS, Gallo MA, Passos MCF, Cindr JM, Cerqueira MC, Vitiello L, Ribeiro ML, Mendonça J, Pedrazzoli-Junior J, Castro LP. New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures. A pilot study. Aliment Pharmacol Ther 2005;21:783-7.
5. Current European Concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
6. Dani R, Queiroz DM, Dias MG, Franco JM, Magalhães LC, Mendes GS, Moreira LS, De Castro LP, Toppa NH, Rocha GA, Cabral MM, Salles PG. Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. Aliment Pharmacol Ther 1999;13:1647-52.
7. Graham DY, Belson G, Abudayyeh S, Osato MS, El-Zimaity HMT, Dore MP. Twice a day (mid-day and evening), quadruple therapy for H. pylori in the United States. Dig Liver Dis 2004;36:377-9.
8. Janowitz HD, Abittan CS, Fiedler LM. A gastroenterological list for the millennium. J Clin Gastroenterol 1999;29:336-8.
9. Kawakami E, Ogata SK, Portorreal AC, Magni AM, Pardo ML, Patrício FR. Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents. Arq Gastroenterol 2001;38:203-6.
10. Lam SK, Talley NJ. Helicobacter pylori Consensus. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998;13:1-12.
11. Magalhaes AF, Macedo C, Hauck JR, Carvalhaes A, De Nucci G, Magna LA, Pedrazzoli J. Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication. Hepatogastroenterology 1998;45:2161-4.
12. Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
13. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-5.
14. Mazzoleni LE. Beneficio sintomatico em população de pacientes com dispepsia funcional após a erradicação do Helicobacter pylori: resultado de estudo de 12 meses, randomizado, duplo-cego, controlado com placebo [tese]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2003.
15. National Institute of Health - Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
16. Nista EC, Candelli M, Cremonini F, Cazzato IA, Di Caro S, Gabrielli M, Santarelli L, Zocco MA, Ojetti V, Carloni E, Cammarota G, Gasbarrini G, Gasbarrini A. Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther 2003;18:627-33.
17. Orsi P, Pinazzi O, Aragona G, di Mario, F. Rabeprazol/levofloxacin based triple therapy as a salvatage treatment after failure of H. pylori eradication with standard regimens. Helicobacter 2003;8:463-4.
18. Passes MCF. Ensaio prospective, randomizado, duplo cego, placebo-controlado do efeito da erradicação do Helicobacter pylori nos pacientes dispépticos funcionais [dissertação]. Belo Horizonte: Universidade Federal de Minas Gerais; 1999.
19. Pinheiro JOP, Both CT, Dietrich S, Zamin JI, Raymondi RP, Muretti I, Mattos AA. Tratamento do Helicobacter pylori: comparação de dois esquemas terapêuticos. GED Gastroenterol Endosc Dig 1999;18:97-101.
20. Sherwood LG. Bismuth therapy in gastrointestinal disease. Gastroenterology 1990;99:863-75.
21. Silva FM, Eisig JN, Chehter EZ, Silva JJ, Laudanna AA. Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease. Rev Hosp Clin Fac Med São Paulo 2002;57:205-8.
22. nd ed. McLean, Virginia. Degnon Associates; 2000. p.299-350.
23. Tytgat GNT. Working party report of the World Congress of Gastroenterology. Helicobacter pylori: causal agent in peptic ulcer disease? Sydney, Australia, 1990.
24. Vieira WLS, Coelho LGV, Castro FJ, Passos MCF, Franco JMM, Moretzsohn LD, Trindade OR, Carvalho SC, Castro LP. Terapia tripla com lansoprazol, claritromicina e amoxicilina, por dez dias, na erradicação do Helicobacter pylori em pacientes com ulcera duodenal. GED Gastroenterol. Endosopia Digestiva 2001;20:201-207.
25. Vieira WLS. Retratamento da infecção pelo Helicobacter pylori em pacientes portadores de úlcra duodenal e seguimento a longo prazo. Ensaio clínico, aberto, prospective e randomizado com dosagens séricas e urinárias de antimicrobianos [tese]. Belo Horizonte: Universidade Federal de Minas Gerais; 2002.
26. Zullo A, Hassan C, De Francesco V, Lorenzetti R, Marignani M, Angeletti S, Ierardi E, Morini S. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig Liver Dis 2003;35:232-6.